ACM
PFE icon

Ayrshire Capital Management’s Pfizer PFE Stock Holding History

Ayrshire Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-18,332
Closed -$569K – 63
2020
Q2 		$569K Buy
18,332
+830
+5% +$28.2K 0.48% 45
2020
Q1 		$542K Sell
17,502
-712
-4% -$24.3K 0.55% 48
2019
Q4 		$677K Buy
+18,214
New +$649K 0.56% 44

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Ayrshire Capital Management's PFE Position: Q3 2020 in Review

Ayrshire Capital Management sold out of Pfizer (PFE) in Q3 2020, closing a stake of 18,332 shares — an estimated $569K sold.

Ayrshire Capital Management first reported a position in PFE in Q4 2019 and held it in 3 quarters. The position peaked at $677K in Q4 2019. 2,508 funds tracked by Wall St. Rank hold PFE as of Q3 2020.

  • Ayrshire Capital Management reported no remaining Pfizer position as of Q3 2020 after selling out during the quarter.
  • Ayrshire Capital Management sold 18,332 Pfizer shares in Q3 2020, an estimated $569K.
  • Ayrshire Capital Management first reported a position in Pfizer in Q4 2019 and held it in 3 quarters.
  • Ayrshire Capital Management's Pfizer position peaked at $677K in Q4 2019.
  • 2,508 funds tracked by Wall St. Rank held Pfizer as of Q3 2020.

Based on Ayrshire Capital Management's 13F filing for Q3 2020, filed 20 Oct 2020.